New Antigens Against Glioblastoma

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 30, 2027

Study Completion Date

September 30, 2027

Conditions
Glioblastoma Multiforme
All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05917821 - New Antigens Against Glioblastoma | Biotech Hunter | Biotech Hunter